.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Healthtrust
Colorcon
Chubb
Mallinckrodt
Harvard Business School
US Army
Queensland Health
Accenture

Generated: November 24, 2017

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for lidocaine hydrochloride and what is the scope of lidocaine hydrochloride patent protection?

Lidocaine hydrochloride
is the generic ingredient in thirty-five branded drugs marketed by Intl Medication, Fresenius Kabi Usa, Hospira, West-ward Pharms Int, Belmora Llc, Abraxis Pharm, Vintage, Bel Mar, Miles, Hi Tech Pharma, Powder Pharms, Oak Pharms, Astrazeneca, G And W Labs Inc, Akorn, Carlisle, Elkins Sinn, Watson Labs, Pharmaton, Bionpharma Inc, B Braun, Kendall Il, Gd Searle Llc, Watson Labs Inc, Aurobindo Pharma Ltd, Mylan Labs Ltd, Meridian Medcl Techn, Luitpold, Abbott, Baxter Hlthcare, Luitpold Pharms Inc, Wockhardt, Actavis Mid Atlantic, Dentsply Pharm, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Sagent Pharms, Teligent Pharma Inc, and Pfizer, and is included in ninety-eight NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine hydrochloride has twenty-three patent family members in twelve countries.

There are twenty-nine drug master file entries for lidocaine hydrochloride. Forty-six suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION088367-001Jul 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
lidocaine hydrochloride; oxytetracycline
INJECTABLE;INJECTION060567-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
lidocaine hydrochloride
INJECTABLE;INJECTION084625-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vintage
LIDOCAINE HYDROCHLORIDE VISCOUS
lidocaine hydrochloride
SOLUTION;ORAL040708-001Feb 27, 2007ATRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION091056-002Dec 8, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Intl Medication
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION018543-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION040013-001Jun 23, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007RXNoNo► Subscribe► Subscribe ► Subscribe
West-ward Pharms Int
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
lidocaine hydrochloride
INJECTABLE;INJECTION084625-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
XYLOCAINE VISCOUS
lidocaine hydrochloride
SOLUTION;ORAL009470-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,044,546Particle cassettes and processes therefor► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine hydrochloride

Country Document Number Estimated Expiration
Australia2015222937► Subscribe
European Patent Office3110404► Subscribe
Singapore11201606034W► Subscribe
Japan3602543► Subscribe
World Intellectual Property Organization (WIPO)9734652► Subscribe
Taiwan201540331► Subscribe
United Kingdom0708758► Subscribe
Argentina066425► Subscribe
World Intellectual Property Organization (WIPO)2015130961► Subscribe
China106975128► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Boehringer Ingelheim
Healthtrust
Chubb
Cipla
Fuji
Deloitte
Moodys
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot